Role of toll-like receptor 4 in intimal foam cell accumulation in apolipoprotein E-deficient mice - Wikidata - wikimedia - TriplyDB

Role of toll-like receptor 4 in intimal foam cell accumulation in apolipoprotein E-deficient mice

Role of toll-like receptor 4 in intimal foam cell accumulation in apolipoprotein E-deficient mice

http://www.wikidata.org/entity/Q34555906

about

Role of gut microbiota in the modulation of atherosclerosis-associated immune response The SYK side of TLR4: signalling mechanisms in response to LPS and minimally oxidized LDL The influence of innate and adaptive immune responses on atherosclerosis 11β-hydroxysteroid dehydrogenase type 1 gene knockout attenuates atherosclerosis and in vivo foam cell formation in hyperlipidemic apoE⁻/⁻ mice Cholesterol-induced non-alcoholic fatty liver disease and atherosclerosis aggravated by systemic inflammation The Role of TLR2, TLR4, and TLR9 in the Pathogenesis of Atherosclerosis Polyoxygenated cholesterol ester hydroperoxide activates TLR4 and SYK dependent signaling in macrophages.IRAK1 mediates TLR4-induced ABCA1 downregulation and lipid accumulation in VSMCs.Toll-like receptor 7 deficiency protects apolipoprotein E-deficient mice from diet-induced atherosclerosis γδT cells are prevalent in the proximal aorta and drive nascent atherosclerotic lesion progression and neutrophilia in hypercholesterolemic mice.Mechanisms of urokinase plasminogen activator (uPA)-mediated atherosclerosis: role of the uPA receptor and S100A8/A9 proteins Distinct gene signatures in aortic tissue from ApoE-/- mice exposed to pathogens or Western diet.The autoimmune concept of atherosclerosis.TLR4-mediated inflammation promotes foam cell formation of vascular smooth muscle cell by upregulating ACAT1 expression.Endotoxin Disrupts Circadian Rhythms in Macrophages via Reactive Oxygen Species TLR4 antagonist attenuates atherogenesis in LDL receptor-deficient mice with diet-induced type 2 diabetes Impact of sphingomyelin synthase 1 deficiency on sphingolipid metabolism and atherosclerosis in mice.Protective role for TLR4 signaling in atherosclerosis progression as revealed by infection with a common oral pathogen.Electrophilic nitro-fatty acids inhibit vascular inflammation by disrupting LPS-dependent TLR4 signalling in lipid rafts.CLI-095 decreases atherosclerosis by modulating foam cell formation in apolipoprotein E-deficient mice.Toll-like receptors in atherosclerosis Toll-like receptor 4 deficiency decreases atherosclerosis but does not protect against inflammation in obese low-density lipoprotein receptor-deficient mice.Monocyte and macrophage dynamics during atherogenesis.Nutritional status, genetic susceptibility, and insulin resistance--important precedents to atherosclerosis.Molecular biology of atherosclerosis.Toll-like receptors: Role in inflammation and therapeutic potential.Inflammation-induced foam cell formation in chronic inflammatory disease.Atherosclerosis and the role of immune cells.Inhibition of Toll-Like Receptor Signaling as a Promising Therapy for Inflammatory Diseases: A Journey from Molecular to Nano Therapeutics.STAT1 and IRF8 in Vascular Inflammation and Cardiovascular Disease: Diagnostic and Therapeutic Potential.C1q/TNF-related protein 9 inhibits the cholesterol-induced Vascular smooth muscle cell phenotype switch and cell dysfunction by activating AMP-dependent kinase.Preclinical models of atherosclerosis. The future of Hybrid PET/MR technology for the early detection of vulnerable plaque.Molecular mechanism of a new Laminaria japonica polysaccharide on the suppression of macrophage foam cell formation via regulating cellular lipid metabolism and suppressing cellular inflammation.Relation between TLR4/NF-κB signaling pathway activation by 27-hydroxycholesterol and 4-hydroxynonenal, and atherosclerotic plaque instability.Oxidized high density lipoprotein induces macrophage apoptosis via toll-like receptor 4-dependent CHOP pathway.Gut Microbiota and Atherosclerosis.miR-223 Inhibits Lipid Deposition and Inflammation by Suppressing Toll-Like Receptor 4 Signaling in Macrophages.Global TLR2 and 4 deficiency in mice impacts bone resorption, inflammatory markers and atherosclerosis to polymicrobial infection.The LPS2 mutation in TRIF is atheroprotective in hyperlipidemic low density lipoprotein receptor knockout mice.The Emerging Role of TLR and Innate Immunity in Cardiovascular Disease.

P2860

Q26801649-A1EB9B95-F375-4550-ADB6-BDB731269DF0 Q26991782-AA3702DD-6590-4017-92E9-F92D6CCA688F Q27000370-2CAC139C-9E16-44D7-BDE9-A3F472381A62 Q27322801-092A5E51-139B-4E00-8098-D25CBBF5EDEE Q27331466-0A669EB9-BA4B-4AAD-8040-5A757B1BE319 Q28077737-EFDC4DB8-B692-4901-AEF0-985A5CE36AE4 Q28537901-5433D3FA-B7C3-4197-9C84-7A002BA499E5 Q33586765-5E277EFC-F09B-4AF4-B2FA-162FAC2BE121 Q33678336-36DE938D-F5C1-4370-9DB6-F7DAC0D257FA Q34337885-E5D20EDF-0DBA-49BA-B3E4-F161F18CC702 Q35063189-BD67BCA3-DB33-40B5-BA2A-F359AE0084F1 Q35201092-2694DBF3-59C2-40EB-8C53-4B361E16E6B9 Q35550211-DF674A47-4723-41DB-8938-EED79158A365 Q35679223-3AE97DB9-0CDB-4D0F-8FDA-FF82765B628D Q36014593-ED6E8F88-3224-4FE6-9B93-4C9DFD54A470 Q36021450-BDD5E10C-26D3-482B-9826-63DF7A878342 Q36239748-A5F7CFE4-559C-4672-9973-8A4123EE2756 Q36252511-0BCD29E8-1F61-4B86-BBE7-B69E7EE6F909 Q36687046-4FE78FCC-591E-43AA-9395-97A30C4A68A7 Q37032384-E6E4ED32-8713-4A52-8695-B69EE2283C21 Q37091891-7759F2F6-08FC-40C8-9354-FD2B7084386C Q37108936-33474AB8-A7CC-4558-BEDF-EF41D3D549A9 Q37890185-1F5F9C81-8759-48EB-A1BD-18CC5B9DD6D6 Q38023791-E6973E3C-F3E7-4904-A144-C599B657A2E3 Q38125279-18B6A5ED-DD17-4FC6-BE62-8868889879D8 Q38174528-E4E9EFA7-CD36-4EDF-B33D-F0BC63B91D6A Q38370895-FA0C762B-3A83-4226-BF8D-484E3C3F238A Q38423257-F5E20919-F1A6-4BFC-B89B-0635C0B704FE Q38557048-77460177-6969-498E-B3F1-556ED15F0433 Q38647432-D53C2858-8C2A-411C-BC86-3165F83A46E1 Q38775075-ECEF56C8-7AB8-4E37-9BE4-084A6EE8DFE2 Q38801539-6C3B8430-2A02-468A-9DA2-322EBA361947 Q38855556-EE4225C7-E858-4B72-B8AD-432C67F9C9AE Q38901560-42D63216-CBFD-4AB1-9211-6DDFC282928B Q39147502-4A889C8C-6A92-4014-BD7B-6773DA36015E Q40079055-FF9749CC-5468-4910-819D-D3A92428BEB2 Q40402994-67BAB0B2-8006-43F6-BBBE-7A3E532CC218 Q40660223-C583D792-46FE-4A13-BEA8-AC5A0E95828F Q42067638-946E194E-2082-4937-AA80-45E2A0BBF62D Q42152131-DDA88C97-6303-4C73-9F61-3DA87E66474E

P2860

Role of toll-like receptor 4 in intimal foam cell accumulation in apolipoprotein E-deficient mice

http://www.wikidata.org/entity/Q34555906

description

2010 nî lūn-bûn

@nan

2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Role of toll-like receptor 4 i ...... polipoprotein E-deficient mice

@ast

Role of toll-like receptor 4 i ...... polipoprotein E-deficient mice

@en

Role of toll-like receptor 4 i ...... polipoprotein E-deficient mice

@nl

type

label

Role of toll-like receptor 4 i ...... polipoprotein E-deficient mice

@ast

Role of toll-like receptor 4 i ...... polipoprotein E-deficient mice

@en

Role of toll-like receptor 4 i ...... polipoprotein E-deficient mice

@nl

prefLabel

Role of toll-like receptor 4 i ...... polipoprotein E-deficient mice

@ast

Role of toll-like receptor 4 i ...... polipoprotein E-deficient mice

@en

Role of toll-like receptor 4 i ...... polipoprotein E-deficient mice

@nl

P1433

Q34555906-5322C771-8C89-43A0-9FAB-2F542D769E83

P1476

Q34555906-9D560783-9ECF-405E-A245-0A276C8FA5B9

P2093

Q34555906-251843C3-A024-4FE0-BC0A-22979411AC0D

Q34555906-26072E7C-5C66-4900-8E68-992414F6673B

Q34555906-50FE3A0F-3985-4CCE-9E14-CADF1B2EF814

Q34555906-A896D2E4-383A-43A5-979B-1F16F6A1D021

Q34555906-F5291A83-94DE-406B-8104-88E044B8AF32

P2860

Q34555906-0D5046FF-D0A0-45D7-A099-F92D7C5E9ED3

Q34555906-0DA936B4-607E-40C8-8EBC-16A4515ACF87

Q34555906-2452EDD1-3987-42BA-A692-D6EBD36B2C8C

Q34555906-261D9859-F9D2-407B-96E1-94006D9C1968

Q34555906-2C252C61-B0A7-4AF7-9EBA-6FDF3132239F

Q34555906-3303F9C5-8F06-4A95-9D43-353329B1C936

Q34555906-4DB0ED19-5730-477E-B754-6BDAE9A34753

Q34555906-4E409D5F-7687-4F28-BDA3-6514B8B8DEFF

Q34555906-53E94187-5D12-42A2-BF36-10593653DFF3

Q34555906-6075BA3B-D68A-48F1-AEDA-9BBDA0A7DA18

P304

Q34555906-4AB12D23-313D-4630-A51F-647986AD69AD

P31

Q34555906-BEE0FCD5-454E-4620-A8A4-1A8A12195460

P356

Q34555906-05A0659E-D272-42A9-81B1-CAEC3DE1B9BE

P407

Q34555906-9195CB36-8169-4F71-BF5A-02F43D42F1B5

P433

Q34555906-066D4ABD-9C1A-4A11-B9C8-63EF435921F7

P478

Q34555906-F3973063-5270-4D5A-802B-D7A6D6CBC6B3

P50

Q34555906-9E28946D-32EF-4221-9350-CDBA6CD69B2D

P577

Q34555906-A0DFEE40-2D20-4A72-A15F-49408ED6D9AD

P5875

Q34555906-6133B88B-8634-4C6F-B1AD-6D31D02B40A1

P698

Q34555906-10B4FF32-B553-404F-89C4-52FB8723A169

P921

Q34555906-65ca4833-8249-4aa3-b965-9e1bb639bc83

P932

Q34555906-A1BF9102-1D8A-4F44-91F3-79CF12549BC9

P356

ATVBAHA.110.210971

P1433

Arteriosclerosis, Thrombosis, and Vascular Biology

P1476

Role of toll-like receptor 4 i ...... polipoprotein E-deficient mice

@en

P2093

Debbie Beasley

http://www.w3.org/2001/XMLSchema#string

Jeffrey B Tatro

http://www.w3.org/2001/XMLSchema#string

Jonas B Galper

http://www.w3.org/2001/XMLSchema#string

Michael E Mendelsohn

http://www.w3.org/2001/XMLSchema#string

Mie Higashimori

http://www.w3.org/2001/XMLSchema#string

P2860

The response-to-retention hypothesis of early atherogenesis

CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer

Mrp8 and Mrp14 are endogenous activators of Toll-like receptor 4, promoting lethal, endotoxin-induced shock

Metabolic endotoxemia initiates obesity and insulin resistance

Role of vascular cell adhesion molecule-1 and fibronectin connecting segment-1 in monocyte rolling and adhesion on early atherosclerotic lesions.

Increased endothelial expression of Toll-like receptor 2 at sites of disturbed blood flow exacerbates early atherogenic events.

Modulation of atherosclerosis in mice by Toll-like receptor 2

Human atherosclerosis. III. Immunocytochemical analysis of the cell composition of lesions of young adults

Potential role of endotoxin as a proinflammatory mediator of atherosclerosis.

Disruption of the acyl-CoA:cholesterol acyltransferase gene in mice: evidence suggesting multiple cholesterol esterification enzymes in mammals.

P304

50-57

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1161/ATVBAHA.110.210971

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

31

http://www.w3.org/2001/XMLSchema#string

P50

Kathryn J Moore

P577

2010-10-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

47520174

http://www.w3.org/2001/XMLSchema#string

P698

20966403

http://www.w3.org/2001/XMLSchema#string

P921

Toll-like receptor

P932

3034636

http://www.w3.org/2001/XMLSchema#string